The rate of people being diagnosed or killed by cancer in the U.S. is
stable or decreasing for men and women, according to a new report. "For
the main cancers, it's really pretty much good news, incidence and
mortality is decreasing," said Recinda Sherman, an author of the new
report from the North American Association of Central Cancer Registries
(NAACCR) in Springfield, Illinois.
A
highlight of the report is that for the first time it breaks breast
cancer into specific groups based on how it responds to hormones, said
Ahmedin Jemal, vice president of surveillance and health service
research at the American Cancer Society (ACS). Triple-negative breast cancer, which is the most aggressive type,
represents about 13 percent of breast cancers for all women, but
represents about 23 percent of breast cancers among black women. Because
triple-negative breast cancer is less likely to be caught by
mammography, Sherman said there may be opportunities to target black
women with messaging about that specific type of breast cancer. The
analysis, published in the Journal of the National Cancer Institute,
is the latest in a series of annual reports on cancer compiled since
1998 by the NAACCR, the ACS, the Centers for Disease Control and
Prevention and the National Cancer Institute. The
organizations found decreases over the past 20 years in the number of
new cases for several of the major cancers diagnosed among men,
including prostate, lung, colon, stomach, brain and throat cancers.
There were also decreases among colon, ovary, cervix, oral and stomach
cancers among women.
Overall, cancer diagnoses decreased by 1.8 percent each year between 2007 and 2011 among men, and remained stable among women.
This site is for information on the various Chemo treatments and Stem Cell Therapies since 1992. This journey became bitter sweet in 2014, with the passing of my beautiful and dear wife. Sherry, had fought Non - Hodgkins Lymphoma(NHL) since 1990, in and out of remissions time and time again. From T-Cell therapies(1990's) to Dual Cord Blood Transplant(2014), she was in Clinical Trials over the years. This site is for informational purpose only and is not to promote the use of certain therapies.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment